At Dadaji Life Science, we aim to make research and development our most utilised department. We never want the people in our community to give up. Our R&D department is consistently working to shed some light on the new path of the pharmaceutical industry in the pursuit of affordable and high-quality medications.
By providing access to the latest technologies and resources, we strive to create a space of excellence for our research and development department.
Our team of experts is constantly analysing the latest trends in the industry and aspiring to improve our products, services, and processes.
The company has leading-edge manufacturing facilities spread over a 17000-square-foot area at Padvala, located 17 kilometres from Rajkot, Gujarat. The facility is based on WHO-cGMP guidelines. It features a multi-product bulk-manufacturing unit with an annual production capacity of over 600 million tablets, 800 million capsules, 100 million Powder Sachets.
We are highly equipped with machines and continuously invest in new technology, automation, and IT-driven systems. which makes us error free and confidential. We are well-respected for our commitment to quality and innovation, which has enabled us to deliver superior products to our customers at competitive prices.
Our manufacturing operations are focused on producing generics, branded generics, Speciality, and over-the-counter (OTC) products in the full range of dosage forms, i.e. Tablets, Capsules and Powder.
Facilities | Tablet, Capsule & Syrup |
Site Area | 17000 Sq Ft |
Built Up Area | 36000 Sq Ft |
Production Area | 12000 Sq Ft |
Storage Area | 2000 Sq Ft |
QA & QC Area | 6000 Sq Ft |
Admin Area | 1200 Sq Ft |
Production Capacity : (Annually) | Tablets – 600 Million/Annum Capsules – 800 Million/Annum Powder -100 Million/Annum |